Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivoMotoo Nagane, Yoshiaki Shiokawa|Neuro-Oncology|2010Cited by 24
Selection of Treatment Modality in Ruptured Cerebral Aneurysms : A Comment on the International Subarachnoid Aneurysm TrialYoshiaki Shiokawa|Japanese Journal of Neurosurgery|2006Cited by 1